The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.

The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.

Bibliográfalaš dieđut
Váldodahkkit:	Turner, M, Kiernan, M
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2014

Geahča maid

Biomarkers in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2009)

Amyotrophic lateral sclerosis.
Dahkki: Kiernan, M, et al.
Almmustuhtton: (2011)

Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?
Dahkki: Turner, M, et al.
Almmustuhtton: (2012)

Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis
Dahkki: T. K. Davydova, et al.
Almmustuhtton: (2018-11-01)

Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis
Dahkki: Kateřina Klíčová, et al.
Almmustuhtton: (2024-01-01)

Kinnier Wilson's puzzling features of amyotrophic lateral sclerosis
Dahkki: Turner, MR, et al.
Almmustuhtton: (2017)

Quantifying disease progression in amyotrophic lateral sclerosis.
Dahkki: Simon, N, et al.
Almmustuhtton: (2014)

Assessment of the upper motor neuron in amyotrophic lateral sclerosis
Dahkki: Huynh, W, et al.
Almmustuhtton: (2016)

The reunification of amyotrophic lateral sclerosis
Dahkki: Turner, M
Almmustuhtton: (2018)

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
Dahkki: Henderson, R, et al.
Almmustuhtton: (2018)

Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.
Dahkki: Hudson, A, et al.
Almmustuhtton: (1993)

Neuroimaging in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2012)

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations
Dahkki: Andrew Eisen, et al.
Almmustuhtton: (2025-02-01)

Controversies and priorities in amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2013)

Untangling neuroinflammation in amyotrophic lateral sclerosis
Dahkki: Thompson, AG, et al.
Almmustuhtton: (2019)

Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis
Dahkki: Tu, S, et al.
Almmustuhtton: (2020)

Multidisciplinary care in amyotrophic lateral sclerosis: a 4-year longitudinal observational study
Dahkki: Eglė Sukockienė, et al.
Almmustuhtton: (2020-06-01)

Neuroimaging endpoints in amyotrophic lateral sclerosis
Dahkki: Menke, R, et al.
Almmustuhtton: (2016)

Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis
Dahkki: Swash, M, et al.
Almmustuhtton: (2020)

Sweet food preference in amyotrophic lateral sclerosis
Dahkki: Turner, M, et al.
Almmustuhtton: (2017)

The tough body at the epicentre of amyotrophic lateral sclerosis
Dahkki: Turner, M, et al.
Almmustuhtton: (2017)

Advances in the application of MRI to amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2010)

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?
Dahkki: Turner, M
Almmustuhtton: (2011)

Defining pre-symptomatic amyotrophic lateral sclerosis
Dahkki: Benatar, M, et al.
Almmustuhtton: (2019)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
Dahkki: Bowser, R, et al.
Almmustuhtton: (2011)

Imaging cerebral activity in amyotrophic lateral sclerosis
Dahkki: Proudfoot, M, et al.
Almmustuhtton: (2019)

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis
Dahkki: Tu, S, et al.
Almmustuhtton: (2018)

Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
Dahkki: Talbot, K, et al.
Almmustuhtton: (2006)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
Dahkki: Evans, M, et al.
Almmustuhtton: (2013)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis
Dahkki: Evans, M, et al.
Almmustuhtton: (2013)

Psychiatric disorders prior to amyotrophic lateral sclerosis
Dahkki: Turner, M, et al.
Almmustuhtton: (2016)

Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis
Dahkki: Turner, M
Almmustuhtton: (2018)

Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis.
Dahkki: Turner, M
Almmustuhtton: (2012)

The genetics of amyotrophic lateral sclerosis
Dahkki: Schymick, J
Almmustuhtton: (2009)

Complicated amyotrophic lateral sclerosis
Dahkki: Miguel González-Diaz, et al.
Almmustuhtton: (2024-01-01)

Myelin imaging in amyotrophic and primary lateral sclerosis.
Dahkki: Kolind, S, et al.
Almmustuhtton: (2013)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
Dahkki: Fabes, J, et al.
Almmustuhtton: (2017)

CSF chitinase proteins in amyotrophic lateral sclerosis
Dahkki: Thompson, A, et al.
Almmustuhtton: (2019)

Motor system biomarkers in amyotrophic lateral sclerosis
Dahkki: Edmond, EC, et al.
Almmustuhtton: (2019)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.
Dahkki: Turner, M, et al.
Almmustuhtton: (2015)